Fidia Farmaceutici S.P.A.
Records under this name other than the patents Fidia Farmaceutici S.P.A. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 58 patents it holds.
Back to Fidia Farmaceutici S.P.A.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,273,063 | Method for Preparing a Rifaximin Product Formerly held In force · Medium confidence | In force | Medium confidence | |
| US 7,935,818 | Process for the preparation and purification of valgancyclovir hydrochloride Formerly held In force · USPTO record | In force | USPTO record | |
| US 8,519,160 | Process for the preparation of rotigotine Formerly held In force · USPTO record | In force | USPTO record | |
| US 9,603,910 | Pharmaceutical compositions containing hyaluronic acid and collagenase for the topical treatment of wounds, burns and ulcers Term ended Term ended Jul 5, 2026 · USPTO record | Term ended | Term ended Jul 5, 2026 | USPTO record |
| US 11,040,089 | Pharmaceutical compositions containing hyaluronic acid and collagenase for the topical treatment of wounds, burns and ulcers Term ended Ended no later than Jul 5, 2026 · USPTO record | Term ended | Ended no later than Jul 5, 2026 | USPTO record |
| US 8,765,714 | Sulphated Hyaluronic Acid for Treating Degenerative Osteoarthritis No holder on record Lapsed on the fee record Ended Jul 1, 2026 · Medium confidence | Lapsed on the fee record | Ended Jul 1, 2026 | Medium confidence |
| US 8,512,752 | Hyaluronic acid derivatives obtained via “click chemistry” crosslinking Lapsed on the fee record Ended Aug 20, 2025 · USPTO record | Lapsed on the fee record | Ended Aug 20, 2025 | USPTO record |
| US 7,838,510 | Biomaterials based on hyaluronic acid for the anti-angiogenic therapy in the treatment of tumors Term ended Term ended Jan 5, 2025 · USPTO record | Term ended | Term ended Jan 5, 2025 | USPTO record |
| US 7,897,584 | Taxanes covalently bounded to hyaluronic acid or hyaluronic acid derivatives Term ended Term ended Jan 4, 2025 · USPTO record | Term ended | Term ended Jan 4, 2025 | USPTO record |
| US 7,462,606 | Ester derivatives of hyaluronic acid for the preparation of hydrogel materials by photocuring Term ended Term ended Sep 16, 2024 · USPTO record | Term ended | Term ended Sep 16, 2024 | USPTO record |